L F Lue - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

L F Lue

Showing results (21-30 of 27) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 27 results.

Neurobiology of Aging|September 1, 1996

Inflammation and Alzheimer's disease pathogenesisJ Rogers, S Webster, L F Lue, et al.

Experimental Neurology|August 25, 2001

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanismL F Lue, D G Walker, L Brachova, et al.

The American Journal of Pathology|September 17, 1999

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's diseaseL F Lue, Y M Kuo, A E Roher, et al.

Neurobiology of Aging|July 1, 1997

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's diseaseS Webster, L F Lue, L Brachova, et al.

Glia|June 26, 2001

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitroL F Lue, R Rydel, E F Brigham, et al.

Molecular Psychiatry|December 11, 2025

Correction: p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseX-Q Yao, S-S Jiao, K Saadipour, et al.

Molecular Psychiatry|April 29, 2015

p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseX-Q Yao, S-S Jiao, K Saadipour, et al.

Pageof 3

Search research articles

Showing results (21-30 of 27) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 27 results.

Neurobiology of Aging|September 1, 1996

Inflammation and Alzheimer's disease pathogenesisJ Rogers, S Webster, L F Lue, et al.

Experimental Neurology|August 25, 2001

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanismL F Lue, D G Walker, L Brachova, et al.

The American Journal of Pathology|September 17, 1999

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's diseaseL F Lue, Y M Kuo, A E Roher, et al.

Neurobiology of Aging|July 1, 1997

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's diseaseS Webster, L F Lue, L Brachova, et al.

Glia|June 26, 2001

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitroL F Lue, R Rydel, E F Brigham, et al.

Molecular Psychiatry|December 11, 2025

Correction: p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseX-Q Yao, S-S Jiao, K Saadipour, et al.

Molecular Psychiatry|April 29, 2015

p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's diseaseX-Q Yao, S-S Jiao, K Saadipour, et al.

Pageof 3